Last reviewed · How we verify

NCT05059886: PREV'AMP SPORT

The Injury and Its Consequences in the Sports Lower Limb Amputee

Completed Last updated 27 October 2022
What this trial tests

trial testing completion of a questionnaire on the practice of sports and possible injuries in Leg Lower Amputation in 45 participants. Completed in 16 June 2022.

Timeline
11 January 2022
Primary endpoint
16 June 2022
16 June 2022

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
StatusCompleted
Study typeOBSERVATIONAL
Enrollment45
Start date11 January 2022
Primary completion16 June 2022
Estimated completion16 June 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

Adults 18 to 65, any sex, with Leg Lower Amputation or Traumatic Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was motivated by the lack of data in the literature on the injury of the major lower limb amputee playing sports and its socio-professional impact. It aims to study sports-related injuries in lower limb amputees. Its objective is to determine the prevalence, but also to describe the injuries (type, location, duration, type of management) and their repercussions in terms of after-effects, and repercussions on sports, professional and personal practice. It also aims to begin a correlation between injury and sports load, type of sport (discipline, practice modality), technical aids used

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05059886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing